Transdermal therapeutic system having improved delivery characteristics
AssigneeAlza Corporation
InventorsPatricia S. Campbell, James B. Eckenhoff
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlza Corporation
InventorsPatricia S. Campbell, James B. Eckenhoff
Estimating the term…
A transdermal therapeutic system using a subsaturated matrix is provided having improved approved release characteristics. Reinforcing means preferably in the form of a fabric are embedded in the upper surface of the subsaturated matrix. At least a portion of the reinforcing means is selected such that the active agent to be delivered to the skin has a solubility, C.sub.r therein which is lower than the initial solubility C.sub.o of the agent in the matrix. In addition, the relationship between the diffusion coefficients of the agent in the matrix D.sub.m and the portion of reinforcing means D.sub.r and the solubilities is given by the relationship: D.sub.r .multidot.C.sub.r <D.sub.m .multidot.C.sub.o. In operation the agent dissolved in the reinforcing means acts as a secondary reservoir improving the release characteristics of the system. Specific embodiments of the invention are particularly adapted for scrotal and labial delivery of drugs such as testosterone and progesterone.
A subsaturated transdermal therapeutic system having improved release characteristics comprising, in combination:
A transdermal therapeutic system particularly adapted for application to sensitive skin surfaces for an extended time period comprising, in combination:
Dependencies are inferred from the claim text.